| Dr Joseph John Angella, MD | |
|
4291 Mangrum Ct, Hollywood, FL 33021-2419 | |
| (954) 981-7262 | |
| (954) 987-8774 |
| Full Name | Dr Joseph John Angella |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 4291 Mangrum Ct, Hollywood, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093046781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME 11581 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph John Angella, MD 4291 Mangrum Court, Hollywood, FL 33021 Ph: (954) 981-7262 | Dr Joseph John Angella, MD 4291 Mangrum Ct, Hollywood, FL 33021-2419 Ph: (954) 981-7262 |
News Archive
USAID Administrator Rajiv Shah on Friday in Iowa described the Obama administration's international agricultural development effort, Feed the Future, as a flagship effort for his agency and a key plank in the administration's global development strategy, but said it can't succeed without more support, CongressDaily reports.
The sole purpose of translational science is to transfer scientific discoveries made in ‘basic research' to clinical reality, to improve the health of individuals and reduce suffering.
Researchers at the Feinstein Institute for Medical Research and the department of neurosurgery at the Hofstra Northwell School of Medicine, announced today that they have published a paper with research findings that could have implications for the treatment of many neurological conditions, including severe traumatic brain injury (TBI).
Genta Incorporated announced that the Company has initiated a new dose-ranging study of tesetaxel, the Company's novel oral tubulin inhibitor, using a weekly dosing regimen. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
SIPPET, a study which involved 42 centers in 14 countries in Europe, North and South America, Africa and Asia was designed to definitively settle the long-debated question whether factor VIII concentrates from different sources (plasma-derived containing VWF or recombinant technology) differ in risk of inhibitor development in previously untreated children (PUPs) with severe hemophilia A.
› Verified 6 days ago
Melanie Areopagita, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4651 Sheridan St, Suite # 270, Hollywood, FL 33021 Phone: 954-989-6000 Fax: 954-967-8962 | |
Prashanth Shanmugham, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1005 N 35th Ave, Hollywood, FL 33021 Phone: 542-656-3019 Fax: 954-985-1434 | |
Ralph William Charlton, MD MAS Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1150 N 35th Ave, Suite 520, Hollywood, FL 33021 Phone: 954-265-6984 Fax: 954-981-5516 | |
Mr. Enrique T Gonzalez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4651 Sheridan St., Suite #270, Hollywood, FL 33021 Phone: 954-989-6000 Fax: 954-378-4775 | |
Ms. Jacinta C Magnus, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4651 Sheridan St., Suite #270, Hollywood, FL 33021 Phone: 954-989-6000 Fax: 954-378-4775 | |
Michael D Strong, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4500 Sheridan St, Hollywood, FL 33021 Phone: 954-966-8000 Fax: 954-966-6614 | |
Suzy Thompson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3950 N 46th Ave, Hollywood, FL 33021 Phone: 954-962-9022 Fax: 954-966-3616 |